Immunosuppresive treatment options in renal transplantation

Gaetano Ciancio, George W Burke, D. Jorge, A. Rosen, J. Miller

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

An overview of the first 4 decades of clinical kidney transplantation would characterize progress primarily in the development of new immunosuppressive agents designed to reduce the incidence and severity of acute rejection to improve short-term outcomes, but with less marked effects on long-term patient and graft survival. The new trend of immunosuppressive therapy is to facilitate long-term allograft and patient survival, and to help to maintain a good quality of life after renal transplantation. To achieve these goals, transplant physicians need to determine the immunosuppressive protocols that will best minimize risk factors associated with reduced allograft/patient survival and quality of life. Recent protocols and clinical experience with modern immunosuppression strategies, as well as the efficacy and safety of various combination protocols, will be reviewed.

Original languageEnglish
Pages (from-to)141-149
Number of pages9
JournalMinerva Urologica e Nefrologica
Volume57
Issue number3
StatePublished - Dec 1 2005

Fingerprint

Immunosuppressive Agents
Kidney Transplantation
Allografts
Quality of Life
Survival
Graft Survival
Clinical Protocols
Immunosuppression
Therapeutics
Physicians
Transplants
Safety
Incidence

Keywords

  • Acute rejection
  • Chronic rejection
  • Immunosuppressive agents
  • Kidney transplantation

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Immunosuppresive treatment options in renal transplantation. / Ciancio, Gaetano; Burke, George W; Jorge, D.; Rosen, A.; Miller, J.

In: Minerva Urologica e Nefrologica, Vol. 57, No. 3, 01.12.2005, p. 141-149.

Research output: Contribution to journalArticle

Ciancio, Gaetano ; Burke, George W ; Jorge, D. ; Rosen, A. ; Miller, J. / Immunosuppresive treatment options in renal transplantation. In: Minerva Urologica e Nefrologica. 2005 ; Vol. 57, No. 3. pp. 141-149.
@article{610a45d33a9049eb921e14f262e54d40,
title = "Immunosuppresive treatment options in renal transplantation",
abstract = "An overview of the first 4 decades of clinical kidney transplantation would characterize progress primarily in the development of new immunosuppressive agents designed to reduce the incidence and severity of acute rejection to improve short-term outcomes, but with less marked effects on long-term patient and graft survival. The new trend of immunosuppressive therapy is to facilitate long-term allograft and patient survival, and to help to maintain a good quality of life after renal transplantation. To achieve these goals, transplant physicians need to determine the immunosuppressive protocols that will best minimize risk factors associated with reduced allograft/patient survival and quality of life. Recent protocols and clinical experience with modern immunosuppression strategies, as well as the efficacy and safety of various combination protocols, will be reviewed.",
keywords = "Acute rejection, Chronic rejection, Immunosuppressive agents, Kidney transplantation",
author = "Gaetano Ciancio and Burke, {George W} and D. Jorge and A. Rosen and J. Miller",
year = "2005",
month = "12",
day = "1",
language = "English",
volume = "57",
pages = "141--149",
journal = "Minerva Urologica e Nefrologica",
issn = "0393-2249",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Immunosuppresive treatment options in renal transplantation

AU - Ciancio, Gaetano

AU - Burke, George W

AU - Jorge, D.

AU - Rosen, A.

AU - Miller, J.

PY - 2005/12/1

Y1 - 2005/12/1

N2 - An overview of the first 4 decades of clinical kidney transplantation would characterize progress primarily in the development of new immunosuppressive agents designed to reduce the incidence and severity of acute rejection to improve short-term outcomes, but with less marked effects on long-term patient and graft survival. The new trend of immunosuppressive therapy is to facilitate long-term allograft and patient survival, and to help to maintain a good quality of life after renal transplantation. To achieve these goals, transplant physicians need to determine the immunosuppressive protocols that will best minimize risk factors associated with reduced allograft/patient survival and quality of life. Recent protocols and clinical experience with modern immunosuppression strategies, as well as the efficacy and safety of various combination protocols, will be reviewed.

AB - An overview of the first 4 decades of clinical kidney transplantation would characterize progress primarily in the development of new immunosuppressive agents designed to reduce the incidence and severity of acute rejection to improve short-term outcomes, but with less marked effects on long-term patient and graft survival. The new trend of immunosuppressive therapy is to facilitate long-term allograft and patient survival, and to help to maintain a good quality of life after renal transplantation. To achieve these goals, transplant physicians need to determine the immunosuppressive protocols that will best minimize risk factors associated with reduced allograft/patient survival and quality of life. Recent protocols and clinical experience with modern immunosuppression strategies, as well as the efficacy and safety of various combination protocols, will be reviewed.

KW - Acute rejection

KW - Chronic rejection

KW - Immunosuppressive agents

KW - Kidney transplantation

UR - http://www.scopus.com/inward/record.url?scp=33745411084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745411084&partnerID=8YFLogxK

M3 - Article

VL - 57

SP - 141

EP - 149

JO - Minerva Urologica e Nefrologica

JF - Minerva Urologica e Nefrologica

SN - 0393-2249

IS - 3

ER -